Furthermore, we show that STIM1-KD increases the susceptibility of thyroid cancer ML-1 cells to drugs used for treatment of thyroid cancer, reinstates the expression of thyroid stimulating hormone receptor (TSHR), thyroid specific proteins and increased iodine uptake. Here, TSHR is linked to thyroid cancer.